Skip to main content
. 2021 Feb 15;13(4):812. doi: 10.3390/cancers13040812

Figure 2.

Figure 2

Progression-free survival in patients treated by TACE versus patients treated by TAE. (A) Progression-free survival without adjustment and (B) progression-free survival adjusted using the propensity score. The results were analyzed using the Kaplan–Meier method and compared using the log rank test. Numbers at risk were reported under the x-axis.